Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-31

Clinical Trial Update: The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study [Phase 2]

View source ↗

Summary

Phase 2 study of NEuroaid for Alzheimer's disease sponsored by National University Hospital, Singapore; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeuroAid

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Alzheimer Disease | Phase 2 | Status: UNKNOWN